Marina Publishes Animal Data on Liposomal Delivery System

One siRNA formulation resulted in greater than 80 percent knockdown of apolipoprotein B, transthyretin, factor VII, and proprotein convertase subtilisin/kexin type 9 mRNA when administered systemically in a 2 mg/kg dose to animal models.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.